Abstract
The article is devoted to the problem of cardiotoxicity of chemotherapy drugs used in cancer patients, the nonspecificity of early clinical manifestations of cardiomyopathy developing against this background, and the search for informative diagnostic techniques to confirm this disease. As an illustration, a clinical case of cardiomyopathy in a young woman who developed against the background of chemotherapy for breast cancer is presented.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
